4 Results for "

ABBV105

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "ABBV105" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-109143
CAS No.: 1643570-24-4
Purity:  ≥98.0%
Synonyms: ABBV-105
Target:  

Btk

Research Areas:  

Inflammation/Immunology

Elsubrutinib (ABBV-105) is an orally active, potent, selective and irreversible Bruton's tyrosine kinase (BTK) inhibitor. The IC50 of Elsubrutinib for BTK catalytic domain is 0.18 μM. Elsubrutinib can be used for the research of inflammatory disease .
loading...
    loading...
Cat. No.: HY-109143B
CAS No.: 1643570-23-3
Purity:  ≥98.0%
Synonyms: (R)-ABBV-105
Target:  

Btk

Research Areas:  

Inflammation/Immunology Cancer

(R)-Elsubrutinib ((R)-ABBV-105) is a Btk inhibitor. (R)-Elsubrutinib can be used in studies of immune diseases (such as rheumatoid arthritis, psoriasis, ankylosing spondylitis, asthma, systemic lupus erythematosus) and cancer .
loading...
    loading...
Cat. No.: HY-109143R
CAS No.: 1643570-24-4
Synonyms: ABBV-105 (Standard)
Target:  

Reference Standards Btk

Research Areas:  

Inflammation/Immunology

Elsubrutinib (Standard) is the analytical standard of Elsubrutinib (HY-109143). This product is intended for research and analytical applications. Elsubrutinib (ABBV-105) is an orally active, potent, selective and irreversible Bruton's tyrosine Kinase (BTK) inhibitor. The IC50 of Elsubrutinib for BTK catalytic domain is 0.18 μM. Elsubrutinib can be used for the research of inflammatory disease .
loading...
    loading...
Cat. No.: HY-109143BR
CAS No.: 1643570-23-3
Synonyms: (R)-ABBV-105 (Standard)
Target:  

Reference Standards Btk

Research Areas:  

Inflammation/Immunology Cancer

(R)-Elsubrutinib (Standard) is the analytical standard of (R)-Elsubrutinib (HY-109143B). This product is intended for research and analytical applications. (R)-Elsubrutinib ((R)-ABBV-105) is a Btk inhibitor. (R)-Elsubrutinib can be used in studies of immune diseases (such as rheumatoid arthritis, psoriasis, ankylosing spondylitis, asthma, systemic lupus erythematosus) and cancer .
loading...
    loading...